Information:
Fel:
ID
30893
Beskrivning
Study part: Logs and Repeats (Logs/Rpts). A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Nyckelord
Versioner (1)
- 2018-07-02 2018-07-02 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
2 juli 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Logs and Repeats (Logs/Rpts) Pazopanib Macular Degeneration MD1103367
Logs and Repeats (Logs/Rpts)
- StudyEvent: ODM
Similar models
Logs and Repeats (Logs/Rpts)
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Date of visit
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
Item Group
ADVERSE EVENT/CONCOMITANT MEDICATION/REPEAT ASSESSMENT CHECK QUESTIONS
C0877248 (UMLS CUI-1)
C2347852 (UMLS CUI-3)
C0681799 (UMLS CUI-5)
C2347852 (UMLS CUI-3)
C0681799 (UMLS CUI-5)
Item
Were any concomitant medications taken by the subject during the study?
text
C2347852 (UMLS CUI [1])
CL Item
Yes (Y)
CL Item
No (N)
Item
Did the subject experience any adverse events during the study?
text
C0877248 (UMLS CUI [1])
CL Item
Yes (Y)
CL Item
No (N)
Item
Were any repeat haematology or clinical chemistry samples taken?
text
C0474523 (UMLS CUI [1])
C0008000 (UMLS CUI [2])
C0008000 (UMLS CUI [2])
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Yes (Y)
CL Item
No (N)
Inga kommentarer